Human trial

Pectin improves physical function in older adults with frailty

In a four-week trial, low-methoxy pectin improved 30-second sit-to-stand scores by 2.07 repetitions compared to 0.71 repetitions with placebo.

GeroScience

In a randomized, double-blind trial of older adults with frailty, researchers tested whether four weeks of low-methoxy pectin supplementation could improve functional, psychological, and biological outcomes. Thirty-one participants enrolled, and 29 completed the trial, receiving either low-methoxy pectin or a placebo. Participants taking pectin improved their lower limb function on the 30-second sit-to-stand test, gaining an average of 2.07 ± 1.94 repetitions compared with 0.71 ± 2.27 in the placebo group. The intervention also reduced anxiety and depression scores and improved quality-of-life domains including physical functioning, vitality, mental health, and social functioning. Pectin did not significantly alter Timed Up and Go scores or circulating inflammatory biomarkers, but it increased the relative abundance of the gut bacterium Coprococcus comes.

Why it matters

Frailty involves concurrent declines in physical performance, mental well-being, and gut microbial balance. Targeted fermentable fibers could offer a low-risk dietary approach to support functional capacity and gut health in vulnerable older populations.

Caveats

The trial was small and short, with only 29 participants completing four weeks of intervention. Pectin produced no significant changes in circulating inflammatory markers or Timed Up and Go performance, and larger trials are needed to verify the results.

The paper

The effect of pectin supplementation on geriatric individuals with frailty: a randomised placebo-controlled dietary intervention study

University of Nottingham · Nottingham University Hospitals NHS Trust

GeroScience · 28 Sep 2026

doi.org/10.1007/s11357-026-02562-8PubMed 42803883